Ryan Kellner's Contact Details

Ryan Kellner's Company Details

Absorption Pharmaceuticals

, N/A, US • 20 - 49 Employees
Major Drugs

Promescent is an FDA-compliant OTC product that helps men to gain PE control, have longer-lasting love making and improve love making satisfaction for both themselves and their partner. The success of the product lies in its proprietary absorption technology, which allows people to maintain sensitivity and avoid transference, which are major side effects of competitive products.. Promescent addresses the PE market which affects approximately 30% of men to varying degrees, a prevalence significantly larger than that of ED, an $8B global market.Promescent has strong support from the U.S. medical community as a solution for men with clinical PE. It's also gaining increasing interest from various forms of media who are recognizing delayed PE and longer-lasting love making as the next big market for male s-xual health. CNBC recently published a report titled "Move Over, Vi-gra. There's a New S-x Drug in Town.""Promescent is owned by Absorption Pharmaceuticals LLC, a US based pharmaceutical company focused on developing a range of exciting pharmaceutical products to improve people's health and relationships.Absorption Pharmaceuticals is a fast-paced organization looking for people who enjoy high levels of autonomy and accountability, able to continuously push themselves to reach new heights.Promescent is in the early stages of crossing over from a medical solution recommended by urologists to a consumer brand with enormous upside potential. The Absorption Pharmaceuticals team is working hard to define this product category and to develop a global brand.